Explore This Research Award in CaptureIQ
Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.
Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- ProtonVDA LLC
- Proposal award date
- 2016-09-22
- Contract end date
- 2019-02-28
- UEI
- C3MKXMVYHKP1
- Solicitation number
- PA15-269
- Topic code
- 102
Research abstract
Proton radiography produces images of patients in terms of proton stopping power by tracking individual
protons before and after the patient and measuring the proton residual range after traversing the patient and
would be the most direct method of image guidance for proton radiation therapy Radiation therapy is needed
for more than of the million Americans who are annually diagnosed with cancer A conservative
estimate from the Mayo Clinic states that new cancer patients each year in the United States could
benefit from proton radiation therapy well above current capacity Proton radiation therapy can potentially
spare large amounts of normal tissue from low to intermediate radiation dose and avoid organs at risk This
reduces late effects and improves quality of life and is especially important for patients with high cure rates
and long survival times There is a clear need to enable more complex treatments delivering a high dose to the
tumor with reduced uncertainty margins There is also a clear need to increase patient throughput and to
improve the cost effectiveness of proton therapy relative to conventional radiation therapy The use of a
proton beam for both imaging and treatment streamlines patient setup and quality assurance procedures
reduces alignment uncertainties and reduces proton range uncertainties Our academic partner previously
participated in the clinical implementation of an analogous strategy applying megavoltage CT to image
guidance for adaptive helical tomotherapy
Our goal is to commercialize a high performance low cost proton radiography system based on well
established fast scintillator technology with optimal proton range resolution and dose to the patient lower than
for equivalent x ray images In Phase II we propose to construct a fully functional prototype of a clinical proton
radiography system with x cm field size mounted on a c arm to accommodate a wide variety of patient
and beam orientations with a CPU GPU workstation for prompt delivery of a reconstructed image and to
perform a series of tests culminating in the production of images of phantoms Our design is high performing
as well as compact simple and monolithic with a low electronics channel count We have chosen an approach
that is conservative and low risk using off the shelf components whenever possible
Our commercialization plan discusses a path to commercialization involving research partners clinical partners
and development partners to achieve the integration of our technology into treatment rooms for clinical use
We have obtained a strong set of letters of support from potential partners indicating a high probability of
commercialization This includes some of the lead authors of Ref who state that it would be natural to
incorporate actual proton radiographs as well as proton facility vendors developers and investors Proton radiation therapy treats cancer while potentially sparing large amounts of normal tissue
from low to intermediate radiation dose and avoiding organs at risk Proton radiography can
precisely target tumors minimizing uncertainty margins while streamlining patient setup and
quality assurance procedures by using a proton beam for both imaging and treatment
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
Research funding history
3 SBIR/STTR records share this UEI (2015–2020). Reported award amounts total $5,244,842. Reported amounts are not federal obligations.
Phases: Phase II, Phase I, Phase II – Direct to Phase II
Agencies: Department of Health and Human Services
Agency intelligence
Department of Health and Human Services
Back to SBIR/STTR Research Awards